Quick Overview: In this segment, Bruce E. Johnson, MD, and Mark A. Socinski, MD, discuss V600E, a specific type of Website: Twitter: Facebook: LinkedIn: ... Melanoma, a type of skin cancer, has become increasingly prevalent in recent years. As medical advancements continue to ...

Braf Explained Debbie Pickworth S - Detailed Overview & Context

In this segment, Bruce E. Johnson, MD, and Mark A. Socinski, MD, discuss V600E, a specific type of Website: Twitter: Facebook: LinkedIn: ... Melanoma, a type of skin cancer, has become increasingly prevalent in recent years. As medical advancements continue to ... Targeted Therapies Forum 2022, Breakout Session: In this video, Dr. Ibiayi Dagogo-Jack gives an in depth Caroline Robert, MD, PhD, head of the Dermatology Unit in Gustave Roussy Cancer Center, Villejuif-Paris, France, discusses ... Learn more about lung cancer at Medical oncologist Dr. Naomi Fujioka shares an overview ...

John L. Marshall, MD, remarks on the burden of Bruce Johnson, MD, Dana-Farber Cancer Institute, Boston, MA, discusses follow-up data from a Phase II trial (NCT01336634) ... Learn more about lung cancer at Medical oncologist and lung cancer expert Dr. Joseph ... Welcome to Day 3 of the 7th Masterclass in Lung Cancer, organized by the Cancer Research and Statistic Foundation (CRSF). Professor Richard Marais tells the story of how our researchers discovered that around half of all melanoma skin cancers carry a ... Alison Schram, MD, Memorial Sloan Kettering Cancer Center, New York, NY, describes the classes of

Tanios Bekaii-Saab, MD; Fortunato Ciardiello, MD, PhD; Paul R. Helft, MD; and John L. Marshall, MD, provide an update on ... Targeted Therapies Forum 2022, Breakout Session: In this video, Dr. Ibiayi Dagogo-Jack discusses treatment of Dr. Laura Boucai discusses conditions under which the BRAFV600E mutation presents increased risk of mortality for patients with ... Keith Flaherty, MD; Rene Gonzalez, MD; and Jeffrey Weber, MD, PhD, discuss the evidence supporting

Photo Gallery

Advice for BRAF Patients: Debbie
Understanding the BRAF-mutated Population in NSCLC
BRAF Explained in Plain English
What is a BRAF-V600E mutation?
Dr. Nathan on Long-Term Outcomes With Dabrafenib/Trametinib in BRAF V600-Mutant Melanoma
Dr. Pavlick on Sequencing Challenges with BRAF-Mutant Melanoma
How is BRAF Testing Done?
BRAF Mutations in NSCLC - 2022 Program: Targeted Therapies Forum
Dr. Robert on 5-Year Analysis of Dabrafenib/Trametinib in BRAF V600-Mutant Melanoma
How do doctors treat lung cancer with BRAF mutations?
BRAF Mutations in Colorectal Cancer
Treating BRAF V600E-mutant NSCLC with dabrafenib and trametinib
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored